92 related articles for article (PubMed ID: 6111982)
1. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
Fekete MI; Elekes I; Kürti M; Borvendég J
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
3. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
Haustein KO; Fiehring H; Oltmanns G; Femmer K
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
[No Abstract] [Full Text] [Related]
4. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
Nakayama K; Oshima T; Koike H
Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
[TBL] [Abstract][Full Text] [Related]
5. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
Darias V; del Río J
Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
[No Abstract] [Full Text] [Related]
7. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
Madan BR; Vyas DS
Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
[No Abstract] [Full Text] [Related]
8. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
[No Abstract] [Full Text] [Related]
9. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
[TBL] [Abstract][Full Text] [Related]
11. Timolol maleate, a new beta-adrenergic receptor blocking agent.
Hall RA; Robson RD; Share NN
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
[No Abstract] [Full Text] [Related]
13. A new type of cardioselective adrenoceptive blocking drug.
Barrett AM; Carter J; Fitzgerald JD; Hull R; Le Count D
Br J Pharmacol; 1973 Jun; 48(2):340P. PubMed ID: 4147428
[No Abstract] [Full Text] [Related]
14. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
Kaiser J; Härtfelder G; Lindner E; Schölkens B
Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
[TBL] [Abstract][Full Text] [Related]
15. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
16. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part I. General pharmacological properties.
Ernest K
Pol J Pharmacol Pharm; 1975; 27(4):363-79. PubMed ID: 241067
[TBL] [Abstract][Full Text] [Related]
19. Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].
Boudot JP; Cavero I; Fénard S; Lefèvre-Borg F; Manoury P; Roach AG
Br J Pharmacol; 1979 Jul; 66(3):445P. PubMed ID: 43176
[No Abstract] [Full Text] [Related]
20. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
Miyagishi A; Nakahara H; Hara Y
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
